Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Withdrawn

• Conditions: Amyotrophic Lateral Sclerosis

• Registration Number: NCT00846560
• Lead Sponsor: Rambam Health Care Campus

Brief Summary

The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Study First Submitted: 2009-02-15
• Study First Submitted QC: 2009-02-17
• Study First Posted: 2009-02-18
• Primary Completion: 2009-07
• Study Completion: 2009-07
• Status Verified: 2017-10
• Last Update Submitted: 2017-10-10
• Last Update Posted: 2017-10-11

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• ALS patients who could sign ICF.

Exclusion Criteria

• No ALS patients age less than 18 years.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Rambam Medical center, Neurology Department; 🇮🇱 Haifa, Israel